AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE3188.75126.1 (+4.12 %)
PREV CLOSE (Rs.) 3062.65
OPEN PRICE (Rs.) 3110.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5364
TODAY'S LOW / HIGH (Rs.)3071.30 3200.00
52 WK LOW / HIGH (Rs.)2335 3314.8
NSE3189.70124.5 (+4.06 %)
PREV CLOSE( Rs. ) 3065.20
OPEN PRICE (Rs.) 3095.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3189.70 (1)
VOLUME 140206
TODAY'S LOW / HIGH(Rs.) 3071.20 3201.90
52 WK LOW / HIGH (Rs.)2329.9 3314.9
Type
Select year
(Rs.in Million)
Particulars
Mar 2026
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Profit Before Tax
13776.50
11891.60
11139.30
7452.50
9094.80
Adjustment
1634.60
1121.10
830.30
1313.00
917.50
Changes In working Capital
-6529.30
1789.30
-997.60
668.50
-2003.90
Cash Flow after changes in Working Capital
8881.80
14802.00
10972.00
9434.00
8008.40
Cash Flow from Operating Activities
5291.90
11572.30
7850.70
7921.10
5617.10
Cash Flow from Investing Activities
-4289.20
-3765.20
653.90
-5596.00
-741.00
Cash Flow from Financing Activities
-1679.20
-7334.10
-10510.60
-1082.00
-4597.10
Net Cash Inflow / Outflow
-676.50
473.00
-2006.00
1243.10
279.00
Opening Cash & Cash Equivalents
1751.20
1294.90
3298.30
2063.60
1775.10
Cash & Cash Equivalent on Amalgamation / Take over / Merger
NA
NA
NA
NA
NA
Cash & Cash Equivalent of Subsidiaries under liquidations
NA
NA
NA
NA
NA
Translation adjustment on reserves / op cash balalces frgn subsidiaries
NA
NA
NA
NA
NA
Effect of Foreign Exchange Fluctuations
NA
NA
NA
NA
NA
Closing Cash & Cash Equivalent
1074.70
1767.90
1292.30
3306.70
2054.10
CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances